A pair of San Antonio biotech companies, BioBridge Global and StemBioSys Inc., have agreed to expand the scope of their collaborative relationship in an effort to bring a new source of stem cells to the research market.
Recent Posts
- Improving CAR-T therapy from within
- ‘A cure on the horizon’: Are we finally close to ending type 1 diabetes?
- Scientists create “smart” DNA drug that targets cancer cells with extreme precision
- Patient deaths prompt concern over regenerative care not covered by insurance
- Biotech IPOs Rebound as AI Takes a More Central Role in Drug Development
- Clinical trial tests new cell therapy to manage kidney transplant rejection

